Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

13

Revenue 2017

Bristol-Myers Squibb

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bristol-Myers Squibb's 2013 sales performance.

Bristol-Myers Squibb

Opdivo improves survival in oesophageal cancer

Opdivo improves survival in oesophageal cancer

BMS releases new data from its phase 3 CHECKMATE-648 study. In interim results released yesterday, Bristol Myers Squibb's (BMS) Opdivo, a PD-(L) 1 checkpoint inhibitor showed improved survival

BMS and bluebird bio gain FDA approval for multiple myeloma therapy

BMS and bluebird bio gain FDA approval for multiple myeloma therapy The US Food and Drug Administration (FDA) has approved Bristol Myers Squibb (BMS) and bluebird bio’s BCMA-targeting CAR T cell therapy Abecma – previously known as ide-cel – for the

J&J’s MS drug ponesimod receives approval in the US

J&J’s MS drug ponesimod receives approval in the US In March 2020, the FDA also approved Bristol Myers Squibb’s (BMS) own S1P receptor modulator Zeposia ( ozanimod) for the treatment of adults with relapsing forms of MS.

FDA accepts BMS’ investigational cardiovascular drug mavacamten for review

FDA accepts BMS’ investigational cardiovascular drug mavacamten for review The US Food and Drug Administration (FDA) is set to review Bristol Myers Squibb’s (BMS) investigational candidate mavacamten for patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM).

FDA advisory committee to review oncology accelerated approvals

FDA advisory committee to review oncology accelerated approvals The Oncology Drugs Advisory Committee will meet to review six indications for Roche’s Tecentriq (atezolizumab), Merck and Co’s Keytruda (pembrolizumab) and Bristol Myers Squibb’s (BMS) Opdivo (nivolumab) in

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
90TEN

90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...

Latest intelligence

01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...
When Will We Be Back To Normal?
The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
How to tell your healthcare story.
Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell....

Infographics